Priority Date: 26.06.12 (US 201261664612P)

BLOOD PLASMA BIOMARKERS FOR BEVACIZUMAB COMBINATION THERAPIES FOR TREATMENT OF BREAST CANCER

  • Application ID: EP13730890
  • Status: EXAMINATION IN PROGRESS

Applicant

Technology company logo small
Technology Company

Attorney

no operation time available
Technology Company

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and G01 (MEASURING; TESTING) is specialized in the combination A61 and G01. We found, that Coller IP Management Ltd, TransMIT GmbH, Kailuweit & Uhlemann, Bock Bieber Donath, Dr. Emil Benatov & Partners - Bulgarian Patent Attorney & Licensed Appraiser and 165 others are specialized in all of these IPC classes. For a similar patent, they might be a good choice.

Timeline

  • 26.06.2012 - Priority Date (US 201261664612P)
  • 03.01.2014 - Publication A1 (WO2014001232)
  • 29.04.2015 - Publication A1 (EP2864788)

IPC Classification